T2 Biosystems Inc (TTOO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
John J. Sperzel
Employees:
180
101 HARTWELL AVENUE, LEXINGTON, MA 02421
781-457-1200

T2 Biosystems, Inc. develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples.

Data derived from most recent annual or quarterly report
Market Cap 47.593 Million Shares Outstanding352.543 Million Avg 30-day Volume 15.78 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-4.68
Price to Revenue0.3657 Debt to Equity-1.0045 EBITDA-56.507 Million
Price to Book Value0.0 Operating Margin-315.0388 Enterprise Value46.262 Million
Current Ratio1.062 EPS Growth0.642 Quick Ratio0.642
1 Yr BETA 1.0148 52-week High/Low 15.0 / 0.09 Profit Margin-370.1265
Operating Cash Flow Growth-10.1352 Altman Z-Score-28.8076 Free Cash Flow to Firm -16.223 Million
Earnings Report2023-08-14
View SEC Filings from TTOO instead.

View recent insider trading info

T2 Biosystems Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TTOO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TTOO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-04-06 by GIBBS MICHAEL TERRENCE
  • 4/A: filed on 2023-04-05 by GIBBS MICHAEL TERRENCE
  • 4: filed on 2023-03-09 by ADAMS LAURA LEE
  • 4: filed on 2023-03-09 by GIFFIN BRETT A.
  • 4: filed on 2023-03-09 by SPRAGUE JOHN M
  • 4: filed on 2023-03-09 by GIBBS MICHAEL TERRENCE
  • 4: filed on 2023-03-09 by SPERZEL JOHN J III
  • 4: filed on 2022-10-13 by BERNARD THIERRY
  • 4: filed on 2022-10-13 by ELSBREE DAVID B
  • 4: filed on 2022-10-13 by SAUNDERS NINFA

    • Events (8k)

  • 8-K: filed on 2023-05-30:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-25:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-23:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-03-31:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-03-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-25:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GIBBS MICHAEL TERRENCE GENERAL COUNSEL

    • Officer
    		 6,612 2023-03-28 4

    SPERZEL JOHN J III CHAIRMAN AND CEO

    • Officer
    • Director
    		 17,329 2023-02-20 1

    SPRAGUE JOHN M CHIEF FINANCIAL OFFICER

    • Officer
    		 7,268 2023-02-20 1

    GIFFIN BRETT A. CHIEF COMMERCIAL OFFICER

    • Officer
    		 841 2023-02-20 2

    ADAMS LAURA LEE

    • Director
    		 732 2022-10-18 2

    CUMMING JOHN W

    • Director
    		 130,000 2022-10-11 2

    LIEBMAN SEYMOUR

    • Director
    		 115,000 2022-10-11 2

    ELSBREE DAVID B

    • Director
    		 115,000 2022-10-11 2

    BERNARD THIERRY

    • Director
    		 115,000 2022-10-11 3

    SAUNDERS NINFA

    • Director
    		 115,000 2022-10-11 3

    TOFT ROBIN

    • Director
    		 115,000 2022-10-11 3

    BARCLAY ALEC CHIEF OPERATIONS OFFICER

    • Officer
    		 181,945 2022-04-08 0

    AHUJA APARNA CHIEF MEDICAL OFFICER

    • Officer
    		 600,000 2022-02-20 0

    MCDONOUGH JOHN

    • Director
    		 516,386 2021-07-01 0

    PARE ANTHONY CHIEF COMMERCIAL OFFICER

    • Officer
    		 31,612 2021-03-17 0

    GOLDMAN SACHS & CO. LLC

    GOLDMAN SACHS GROUP INC

    • 10% Owner
    		 4,201,582 2020-03-24 0

    JONES ADRIAN M

    • Director
    		 4,201,582 2020-03-24 0

    LOWERY THOMAS J. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2020-03-14 0

    CIMA MICHAEL J.

    • Director
    		 213,178 2019-06-11 0

    LAPIDUS STANLEY

    • Director
    		 53,010 2019-06-11 0

    DEPTULA-HICKS DARLENE M SVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 4,000 2017-06-06 0

    DHANDA RAHUL SVP OF CORPORATE DEVELOPMENT

    • Officer
    		 5,667 2017-06-06 0

    SPADORO JOANNE CHIEF OPERATIONS OFFICER

    • Officer
    		 5,589 2017-06-06 0

    HARDING DAVID CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2017-02-09 0

    LYNCH SHAWN CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2017-02-09 0

    CANON U.S.A., INC.

    CANON INC

    • 10% Owner
    		 6,055,341 2016-09-21 0

    WILCOX HARRY W

    • Director
    		 0 2016-06-17 0

    BILENKER JOSHUA H.

    • Director
    		 0 2016-06-17 0

    PFALLER MICHAEL A. CHIEF MEDICAL OFFICER

    • Officer
    		 0 2016-01-20 0

    KALIL SARAH O. CHIEF OPERATING OFFICER

    • Officer
    		 0 2016-01-20 0

    GOLDMAN SACHS GROUP INC

    GOLDMAN SACHS & CO

    BROAD STREET PRINCIPAL INVESTMENTS, L.L.C.

    BRIDGE STREET 2013 HOLDINGS, L.P.

    BRIDGE STREET 2013 OFFSHORE, L.P.

    BRIDGE STREET 2013, L.P.

    BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C.

    MBD 2013 HOLDINGS, L.P.

    MBD 2013, L.P.

    MBD 2013 OFFSHORE, L.P.

    • 10% Owner
    		 4,157,240 2015-12-09 0

    AISLING CAPITAL III LP

    AISLING CAPITAL PARTNERS III LP

    AISLING CAPITAL PARTNERS III LLC

    ELMS STEVE

    SCHIFF ANDREW N

    PURCELL DENNIS J

    • Director
    • 10% Owner
    		 2,830,992 2015-12-09 0

    CARELLA THOMAS J.

    • Director
    		 4,174,887 2015-12-09 0

    MBD ADVISORS, L.L.C.

    • 10% Owner
    		 4,157,240 2015-12-09 0

    CASTONGUAY MAURICE L CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2015-08-06 0

    POLARIS VENTURE PARTNERS V, L.P.

    POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

    POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

    • 10% Owner
    		 2,206,723 2015-08-05 0

    LAPIDUS STANLEY N

    • Director
    		 0 2015-06-19 0

    FLAGSHIP VENTURES FUND 2004 L P

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • 10% Owner
    		 2,374,571 2014-08-12 0

    CRANE ALAN L

    • Director
    		 30,000 2014-08-12 0

    CRANE ALAN L

    POLARIS VENTURE PARTNERS V, L.P.

    POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

    POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

    • Director
    • 10% Owner
    		 0 2014-08-06 0

    JONES MARC R. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2014-08-06 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    T2 BIOSYSTEMS INC TTOO 2023-05-31 22:15:04 UTC -11.4751 16.5351 550000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 21:45:04 UTC -11.4751 16.5351 550000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 21:15:03 UTC -11.4751 16.5351 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 20:45:04 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 20:15:06 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 19:45:04 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 19:15:21 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 18:45:03 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 18:15:04 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 17:45:03 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 17:15:05 UTC -11.4751 16.5351 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 16:45:04 UTC -13.3084 18.3784 450000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 16:15:04 UTC -13.3084 18.3784 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 15:45:03 UTC -13.3084 18.3784 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 15:15:04 UTC -13.3084 18.3784 550000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 14:45:04 UTC -13.3084 18.3784 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 14:15:03 UTC -13.3084 18.3784 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 13:45:04 UTC -22.3154 27.3854 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 13:15:04 UTC -22.3154 27.3854 600000
    T2 BIOSYSTEMS INC TTOO 2023-05-31 12:45:04 UTC -22.3154 27.3854 850000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TTOO -548.0 shares, $-252.08 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments